Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Mar. 31, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of test monitoring costs and royalty fees

 

 

 

Year Ended March 31,

 

 

 

2015

 

2016

 

2017

 

 

 

RMB

 

RMB

 

RMB

 

 

 

 

 

 

 

 

 

Test monitoring costs

 

113,042,449

 

142,116,286

 

163,061,810

 

Royalty fees

 

4,991,524

 

4,823,101

 

7,423,118

 

 

Schedule of useful lives of property and equipment

                                                                                                                                                                                                  

Building

 

30 years

Computer equipment

 

3 to 5 years

Furniture, fixtures and office equipment

 

5 years

Software

 

3 to 5 years

Motor vehicles

 

5 years

Leasehold improvements

 

The shorter of lease terms and estimated useful lives

 

Schedule of allocation of recognized employee benefit expenses

 

 

 

Year Ended March 31,

 

 

 

2015

 

2016

 

2017

 

 

 

RMB

 

RMB

 

RMB

 

Cost of revenues

 

5,597,846

 

6,334,414

 

6,841,587

 

Research and development

 

5,563,607

 

5,810,237

 

6,435,010

 

Sales and marketing

 

4,045,878

 

4,169,401

 

4,463,283

 

General and administrative

 

2,870,561

 

2,583,837

 

3,110,561

 

 

 

 

 

 

 

 

 

Total expense due to employee benefit plans

 

18,077,892

 

18,897,889

 

20,850,441

 

 

 

 

 

 

 

 

 

 

Schedule of the Company's involvement with the VIE under the VIE Agreements affected the consolidated results of operations and cash flows

 

 

 

Year ended March 31, 2015

 

 

 

RMB

 

Net revenue

 

154,454,044

 

Net income

 

21,951,065

 

 

 

 

Year ended March 31, 2015

 

 

 

RMB

 

Net cash provided by operating activities

 

22,655,696

 

Net cash used in investing activities

 

(37,956,001

)

Net cash used in financing activities